VALLI, DEBORA
VALLI, DEBORA
Dipartimento di Oncologia ed Emato-Oncologia
HDAC8 promotes hematopoietic stem and progenitor cells proliferation with implications in acute myeloid leukemia
2021 M. Spreafico, A. Gruszka, D. Valli, M. Mazzola, G. Deflorian, A. Quintè, M. Totaro, C. Battaglia, M. Alcalay, A. Marozzi, A. Pistocchi
DRUG REPURPOSING FOR THE TREATMENT OF ACUTE MYELOID LEUKAEMIA WITH ADVERSE PROGNOSIS
2020 D. Valli
Has drug repurposing fulfilled its promise in acute myeloid leukaemia?
2020 D. Valli, A.M. Gruszka, M. Alcalay
HDAC8 : A Promising Therapeutic Target for Acute Myeloid Leukemia
2020 M. Spreafico, A.M. Gruszka, D. Valli, M. Mazzola, G. Deflorian, A. Quinte, M.G. Totaro, C. Battaglia, M. Alcalay, A. Marozzi, A. Pistocchi
A Novel Platform to Test In Vivo Single Gene Dependencies in t(8,21) and t(15,17) AML Confirms Zeb2 as Leukemia Target
2020 G. De Conti, A.M. Gruszka, D. Valli, A.U. Cammarata, M. Righi, M. Mazza, P.G. Pelicci
Wnt Signalling in Acute Myeloid Leukaemia
2019 A.M. Gruszka, D. Valli, M. Alcalay
BET Inhibition-Induced GSK3β Feedback Enhances Lymphoma Vulnerability to PI3K Inhibitors
2018 E. Derenzini, P. Mondello, T. Erazo, A. Portelinha, Y. Liu, M. Scallion, Z. Asgari, J. Philip, P. Hilden, D. Valli, A. Rossi, H. Djaballah, O. Ouerfelli, E. de Stanchina, V.E. Seshan, R.C. Hendrickson, A. Younes
Understanding the molecular basis of acute myeloid leukemias : where are we now?
2017 A. M Gruszka, D. Valli, M. Alcalay
Nucleophosmin leukemogenic mutant activates Wnt signaling during zebrafish development
2016 E. Barbieri, G. Deflorian, F. Pezzimenti, D. Valli, M. Saia, N. Meani, A.M. Gruszka, M. Alcalay
AML1/ETO accelerates cell migration and impairs cell-to-cell adhesion and homing of hematopoietic stem/progenitor cells
2016 M. Saia, A. Termanini, N. Rizzi, M. Mazza, E. Barbieri, D. Valli, P. Ciana, A.M. Gruszka, M. Alcalay